Rintatolimod
Rintatolimod
Rintatolimod (pronounced rin-ta-to-li-mod) is a drug that is primarily used in the treatment of Chronic Fatigue Syndrome (CFS). It is an experimental immunomodulatory agent developed by Hemispherx Biopharma.
Etymology
The name "Rintatolimod" is derived from the chemical structure of the drug. The prefix "Rin-" is derived from the Latin word "Rinere", which means to flow or stream, referring to the drug's mechanism of action in the body. The suffix "-tolimod" is a common suffix used in the naming of immunomodulatory drugs.
Usage
Rintatolimod is used in the treatment of Chronic Fatigue Syndrome (CFS), a complex and debilitating chronic illness that affects the brain and multiple body systems. It works by stimulating the immune system and is thought to help improve the symptoms of CFS.
Related Terms
- Immunomodulatory: Refers to the ability to modify or regulate the immune system.
- Chronic Fatigue Syndrome: A complex and debilitating chronic illness that affects the brain and multiple body systems.
- Hemispherx Biopharma: A biopharmaceutical company that developed Rintatolimod.
See Also
External links
- Medical encyclopedia article on Rintatolimod
- Wikipedia's article - Rintatolimod
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski